An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase 1/11a trial in Thai volunteers at low risk of HIV infection

Por Hemachandra, Atchriya, Puls, Rebekah L, Sirivichayakul, Sunee, Kerr, Stephen, Thantiworasit, Pattarawat, Ubolyam, Sasiwimol, Cooper, David A, Emery, Sean, Phanuphak, Praphan, Kelleher, Anthony, Ruxrungtham, Kiat
Publicado em 2010

No Increase in Hepatitis B Virus (HBV)-Specific CD8(+) T Cells in Patients with HIV-1-HBV Coinfections following HBV-Active Highly Active Antiretroviral Therapy

Por Crane, Megan, Sirivichayakul, Sunee, Chang, J. Judy, Avihingsanon, Anchalee, Ubolyam, Sasiwimol, Buranapraditkun, Supranee, Thantiworasit, Pattarawat, Wightman, Fiona, Locarnini, Stephen, Matthews, Gail, Dore, Gregory J., Ruxrungtham, Kiat, Lewin, Sharon R.
Publicado em 2010